Clinical study of repairing effect of basic fibroblast growth factor on epithelium, endothelium and nerves after laser assisted in situ keratomileusis
Ying LI,Liu-Xue-Ying ZHONG,Zheng WANG,Xing-Wu ZHONG,Guo-Fu HUANG,Shao-Zhen ZHAO,Yu-Mei JIN
DOI: https://doi.org/10.13389/j.cnki.rao.2008.02.021
2008-01-01
Abstract:Objective To observe the clinical therapeutic effects of recombinant basic fibroblast growth factor (rbFGF) on rational symptomatic relief and repair of corneal epithelium,endothelium and nerves after laser assisted in situ keratomileusis (LASIK).Methods The post-LASIK patients were enrolled in a certain period.They were divided randomly into treatment group and control group,30 cases (60 eyes) in each group.1 g·L-1 fluorometholone eye drops and 3 g·L-1 ofloxacin eye drops were given four times a day after the operation,adding rbFGF eye drops to treatment group and Sodium Hyaluronate eye drops to control group 4 times a day for three months.Rational symptoms,objective signs and compliance were parallel compared and global assessed at the 1st day,2nd week,1st month and 3rd month after operation.The rational symptoms included asthenopia,blurring,foreign body feeling,dryness of eye and stabbing pain,and signs like visual acuity,tear break-up time,Schirmer’s TestⅠ,corneal epithelial fluorescein staining,neovascularization (NV),haze,corneal endothelium counting and corneal sensation.All of these data were processed with SPSS 11.5,and P<0.05 indicates statistical difference.Results There was no difference in both groups on sex,age and naked vision preoperatively (P>0.05).All the symptoms were relieved after therapy (P<0.01) in each group,except dryness of eye.Corneal epithelium FS increased in earlier postoperative period in each group,then notably decreased after treatment (P<0.01).Schirmer’s TestⅠvalue of tested group improved after therapy (P<0.05).Schirmer’s TestⅠvalue of control group,and break-up time and corneal endothelium counting of each group were no differences (P>0.05) between pre-operation and post-operation.Corneal sensation reduced in earlier postoperative period in each group,then recovered gradually,and there was a notably statistical difference between pre-operation and post-operation eyes in each group (P<0.01).There was no occurrence of NV or aggravation in each group.It was same to haze.Tolerance and safety of therapy of both groups were good.After treated with rbFGF and Sodium Hyaluronate,stabbing pain of patients in control group was better relieved than in treatment group (P<0.05) at the 2nd weeks postoperatively,and others were similar between two groups.The integrated subjective symptom was relieved in both groups,and the total score of five symptoms of treatment group at the 2nd weeks postoperatively was significantly better relieved than in control group (P<0.05).The postoperative 1st day,2nd weeks,1st month and 3rd months achieving naked visual acuities in treatment group were 0.99±0.28,1.06±0.25,1.11±0.210 and 1.14±0.21,while in control group were 1.05±0.28,1.16±0.20,1.22±.193 and 1.14±0.17.There was no difference between two groups(P>0.05).Average tear secretion (Schirmer’s Test) of treatment group was better than in control group just at the 2nd weeks postoperatively(P<0.05).Other signs were no differences(P>0.05) between two groups.Conclusion rbFGF is safe and better comfortable to the patients of post-LASIK.It may relieve postoperative superficial ocular irritations,benefit to epithelium and nerves repairing and protecting,and promote tear secretion.There is neither NV occurrence nor aggravation,and no haze appeares in each group.